All News

A new study found that it’s safe for patients with HIV to receive HIV-positive kidneys.

Juven, a therapeutic wound healing drink from Abbott, has hit the shelves of CVS Pharmacy locations, according to a press release.

Both premenopausal and postmenopausal breast cancer rates are rising globally.

Evidence suggests that individuals who have more severe COVID-19 illness requiring hospitalization may still have symptoms that persist even after recovery from infection.

The project aims to demonstrate the value of collaboration between pharmacists and health care payers in the delivery of patient-centered care.

Pharmacy Times spoke with Ron Lanton, Principal at Lanton Law, about Rutledge v. PCMA and its impact on pharmacy and PBMs.

Although the treatment of cancer is facing many challenges, the pandemic is also creating massive amounts of new data with which to educate patients, conduct new research, and make more informed clinical decisions.

New research suggests vitamin D can help prevent colitis in those using immune checkpoint inhibitors.

Working memory development plateaus in the mid-to-late teens and can begin to decline after age 40.

The researchers found that the effect of ACE inhibitors does not appreciably affect the levels of ACE2 enough to support any changes in the clinical use of these medications.

Which vitamin is so dangerous you can actually get too much of it in food form?

Medical device and pharma industry veteran will help expand first FDA-cleared computerized test of cognitive function.

Brexucabtagene autoleucel (Tecartus, Kite Pharma) is indicated for adult patients diagnosed with mantle cell lymphoma (MCL) who have not responded to or who have relapsed following other kinds of treatment.